BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

335 related articles for article (PubMed ID: 17200160)

  • 1. The calcimimetic R-568 increases vitamin D receptor expression in rat parathyroid glands.
    Rodriguez ME; Almaden Y; Cañadillas S; Canalejo A; Siendones E; Lopez I; Aguilera-Tejero E; Martin D; Rodriguez M
    Am J Physiol Renal Physiol; 2007 May; 292(5):F1390-5. PubMed ID: 17200160
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The roles of calcium and 1,25-dihydroxyvitamin D3 in the regulation of vitamin D receptor expression by rat parathyroid glands.
    Brown AJ; Zhong M; Finch J; Ritter C; Slatopolsky E
    Endocrinology; 1995 Apr; 136(4):1419-25. PubMed ID: 7895652
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Direct upregulation of parathyroid calcium-sensing receptor and vitamin D receptor by calcimimetics in uremic rats.
    Mendoza FJ; Lopez I; Canalejo R; Almaden Y; Martin D; Aguilera-Tejero E; Rodriguez M
    Am J Physiol Renal Physiol; 2009 Mar; 296(3):F605-13. PubMed ID: 19091789
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Calcimimetics normalize the phosphate-induced stimulation of PTH secretion in vivo and in vitro.
    Almaden Y; Rodriguez-Ortiz ME; Canalejo A; Cañadillas S; Canalejo R; Martin D; Aguilera-Tejero E; Rodríguez M
    J Nephrol; 2009; 22(2):281-8. PubMed ID: 19384847
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Calcimimetic compound upregulates decreased calcium-sensing receptor expression level in parathyroid glands of rats with chronic renal insufficiency.
    Mizobuchi M; Hatamura I; Ogata H; Saji F; Uda S; Shiizaki K; Sakaguchi T; Negi S; Kinugasa E; Koshikawa S; Akizawa T
    J Am Soc Nephrol; 2004 Oct; 15(10):2579-87. PubMed ID: 15466262
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Simultaneous changes in the calcium-sensing receptor and the vitamin D receptor under the influence of calcium and calcitriol.
    Carrillo-López N; Alvarez-Hernández D; González-Suárez I; Román-García P; Valdivielso JM; Fernández-Martín JL; Cannata-Andía JB
    Nephrol Dial Transplant; 2008 Nov; 23(11):3479-84. PubMed ID: 18556746
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Apoptosis: a possible mechanism of suppressing parathyroid hyperplasia by calcimimetics].
    Mizobuchi M; Saji F; Shiizaki K; Sato T; Shibata M; Negi S; Akizawa T; Hatamura I; Ogata H; Kinugasa E
    Clin Calcium; 2005 Sep; 15 Suppl 1():56-8; discussion 58-9. PubMed ID: 16272631
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Development of parathyroid gland hyperplasia without uremia: role of dietary calcium and phosphate.
    Canalejo A; Canalejo R; Rodriguez ME; Martinez-Moreno JM; Felsenfeld AJ; Rodríguez M; Almaden Y
    Nephrol Dial Transplant; 2010 Apr; 25(4):1087-97. PubMed ID: 19934096
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Regulation of parathyroid vitamin D receptor expression by extracellular calcium.
    Garfia B; Cañadillas S; Canalejo A; Luque F; Siendones E; Quesada M; Almadén Y; Aguilera-Tejero E; Rodríguez M
    J Am Soc Nephrol; 2002 Dec; 13(12):2945-52. PubMed ID: 12444213
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Heterogeneous expression of receptor mRNAs in parathyroid glands of secondary hyperparathyroidism.
    Välimäki S; Farnebo F; Forsberg L; Larsson C; Farnebo LO
    Kidney Int; 2001 Nov; 60(5):1666-75. PubMed ID: 11703583
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Calcification inhibitors and Wnt signaling proteins are implicated in bovine artery smooth muscle cell calcification in the presence of phosphate and vitamin D sterols.
    Shalhoub V; Shatzen E; Henley C; Boedigheimer M; McNinch J; Manoukian R; Damore M; Fitzpatrick D; Haas K; Twomey B; Kiaei P; Ward S; Lacey DL; Martin D
    Calcif Tissue Int; 2006 Dec; 79(6):431-42. PubMed ID: 17171500
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Upregulation of parathyroid VDR expression by extracellular calcium is mediated by ERK1/2-MAPK signaling pathway.
    Cañadillas S; Canalejo R; Rodriguez-Ortiz ME; Martinez-Moreno JM; Estepa JC; Zafra R; Perez J; Muñoz-Castañeda JR; Canalejo A; Rodriguez M; Almaden Y
    Am J Physiol Renal Physiol; 2010 May; 298(5):F1197-204. PubMed ID: 20181667
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Reduced parathyroid vitamin D receptor messenger ribonucleic acid levels in primary and secondary hyperparathyroidism.
    Carling T; Rastad J; Szabó E; Westin G; Akerström G
    J Clin Endocrinol Metab; 2000 May; 85(5):2000-3. PubMed ID: 10843188
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Discovery of a calcimimetic with differential effects on parathyroid hormone and calcitonin secretion.
    Henley C; Yang Y; Davis J; Lu JY; Morony S; Fan W; Florio M; Sun B; Shatzen E; Pretorius JK; Richards WG; St Jean DJ; Fotsch C; Reagan JD
    J Pharmacol Exp Ther; 2011 Jun; 337(3):681-91. PubMed ID: 21422163
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Tricking the parathyroid gland with novel calcimimetic agents.
    Nemeth EF; Bennett SA
    Nephrol Dial Transplant; 1998 Aug; 13(8):1923-5. PubMed ID: 9719139
    [No Abstract]   [Full Text] [Related]  

  • 16. NPS R-568: a type II calcimimetic compound that acts on parathyroid cell calcium receptor of rats to reduce plasma levels of parathyroid hormone and calcium.
    Fox J; Lowe SH; Petty BA; Nemeth EF
    J Pharmacol Exp Ther; 1999 Aug; 290(2):473-9. PubMed ID: 10411552
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Vitamin D receptor agonist VS-105 directly modulates parathyroid hormone expression in human parathyroid cells and in 5/6 nephrectomized rats.
    Sawada K; Wu-Wong JR; Chen YW; Wessale JL; Kanai G; Kakuta T; Fukagawa M
    J Steroid Biochem Mol Biol; 2017 Mar; 167():48-54. PubMed ID: 27989797
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Persistent downregulation of calcium-sensing receptor mRNA in rat parathyroids when severe secondary hyperparathyroidism is reversed by an isogenic kidney transplantation.
    Lewin E; Garfia B; Recio FL; Rodriguez M; Olgaard K
    J Am Soc Nephrol; 2002 Aug; 13(8):2110-6. PubMed ID: 12138143
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Exclusive underexpression of vitamin D receptor exon 1f transcripts in tumors of primary hyperparathyroidism.
    Correa P; Akerstrom G; Westin G
    Eur J Endocrinol; 2002 Nov; 147(5):671-5. PubMed ID: 12444900
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Calcimimetics with potent and selective activity on the parathyroid calcium receptor.
    Nemeth EF; Steffey ME; Hammerland LG; Hung BC; Van Wagenen BC; DelMar EG; Balandrin MF
    Proc Natl Acad Sci U S A; 1998 Mar; 95(7):4040-5. PubMed ID: 9520489
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.